News
Media
Academy
Conferences
Publications
CME/CE
Job Board
Subscribe
Directories

Spotlight -

Concierge Medicine Forum|

News|Videos|December 24, 2024

Private equity in health care: Physicians provide the lowest-cost care

Author(s)Richard Payerchin

Key Takeaways

AIMPA's 2024 study analyzed healthcare costs across different physician employment models, including private equity-backed practices.
Independent physicians with financial backing can provide care at lower costs than hospitals and health systems.
The study challenges the cost-effectiveness of traditional healthcare institutions, highlighting the potential of supported independent practices.

SHOW MORE

The leader of the American Independent Medical Practice Association discusses the state of private equity investment in health care.

In 2024, AIMPA commissioned a formal study of health care cost across models of different physician employment, including unaffiliated practices with private equity investment. AIMPA Board Chair and President Paul Berggreen, MD explains results. Spoiler alert: Physicians with financial support to operate independently can provide care at a lower cost than hospitals and health systems.

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Related Content

Morning Medical Update © kwanchaichaiudom - stock.adobe.com

GLP-1 has proven benefits outside of weight loss; healthy hums, healthy brain; off-the-shelf cell therapy fights breast cancer – Morning Medical Update

ByAustin Littrell

October 23rd 2025

Defining AI liability: Why accountability in the AI era is still a gray zone

Defining AI liability: Why accountability in the AI era is still a gray zone

ByAustin Littrell

October 22nd 2025

Defining AI liability: What past device lawsuits can teach physicians

Defining AI liability: What past device lawsuits can teach physicians

ByAustin Littrell

October 22nd 2025

Defining AI liability: How AI could redefine the standard of care

Defining AI liability: How AI could redefine the standard of care

ByAustin Littrell

October 22nd 2025

Defining AI liability: Self-driving cars

Defining AI liability: Self-driving cars

ByAustin Littrell

October 22nd 2025

Latest CME

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

Tina Bhutani, MD, MAS, FAAD; Jason E. Hawkes MD, MS

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

MJH Life Sciences acquires BPD Healthcare, expands its reach into hospital, health system space

Increasing costs, declining value: U.S. health care at a crossroads

Defining AI liability: Why accountability in the AI era is still a gray zone

FDA-cleared neurostimulation device shows promise in reducing opioid, stimulant use, study finds

Fujifilm launches advanced endoscopy platform with new imaging capabilities

© 2025 MJH Life Sciences^®

All rights reserved.